Rate My Professor Emma Morton

Dr. Emma Morton is a Senior Lecturer (Teaching and Research) in the School of Psychological Sciences, Faculty of Medicine, Nursing and Health Sciences, at Monash University. She earned her PhD in Clinical Psychology from Swinburne University of Technology in 2018, where she also completed her clinical training as a psychologist. Subsequently, she undertook postdoctoral research at the University of British Columbia in Canada, supported by the Institute of Mental Health Marshall Fellowship from 2019 to 2021 and the Canadian Institutes of Health Research Banting Postdoctoral Fellowship from 2021 to 2023. As a registered psychologist, she leads the Emma Morton Laboratory, which is part of the Mental Health and Wellbeing Program and affiliated with the Turner Institute for Brain and Mental Health. She is also co-director of CREST.BD, the Collaborative Research Team to Study Psychosocial Issues in Bipolar Disorder.

Dr. Morton's research aims to optimize the health and quality of life of people living with mood disorders, particularly bipolar spectrum disorders. Her work encompasses three intersecting streams: measuring and predicting patient-valued outcomes in mood disorders; developing and evaluating psychological interventions, including compassion-focused interventions, peer support, and psychedelic-assisted therapies; and improving access to and delivery of psychological interventions via self-management education, clinician training, and digital health tools. She utilizes mixed quantitative and qualitative methods within a community-based participatory research framework and contributes to UN Sustainable Development Goal 3: Good Health and Well-being. Dr. Morton has received numerous awards, including the Banting Postdoctoral Fellowship (2021), two Best Poster Awards (2021 and 2022), the Early Career Researcher Potential Award (2022), and the Institute of Mental Health Marshall Fellowship. With over 50 research outputs, notable publications include “The Type, Impacts, and Experiences of Peer Support for People Living With Bipolar Disorder: A Scoping Review” (Bipolar Disorders, 2025), “Digital tools to facilitate the detection and treatment of bipolar disorder - Key developments and future directions” (JMIR Mental Health, 2024), “Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey” (Journal of Psychopharmacology, 2023), “The Quality of Life in Bipolar Disorder (QoL.BD) Questionnaire a decade on: A systematic review” (Journal of Affective Disorders, 2021), and “Quality of life in bipolar disorder: Towards a dynamic understanding” (Psychological Medicine, 2018). She supervises PhD students and engages in knowledge translation to support clinical practice.